“A Prospective Clinical Study for Safety and Efficacy of Intralesional Tuberculin Purified Protein Derivative in Treatment of Palmoplantar Verruca”, J Nobel Med Coll, vol. 11, no. 1, pp. 12–16, Jun. 2022, doi: 10.3126/jonmc.v11i1.45720.